Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States.
Chesson, Harrell W; Ekwueme, Donatus U; Saraiya, Mona; Watson, Meg; Lowy, Douglas R; Markowitz, Lauri E.
; 30(42): 6016-9, 2012 Sep 14.
Artigo em Inglês | MEDLINE | ID: mdl-22867718
Annual prevalence and economic burden of genital warts in Korea: Health Insurance Review and Assessment (HIRA) service data from 2007 to 2015.
A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.
BRICS: opportunities to improve road safety.
Tuberculosis control and economic recession: longitudinal study of data from 21 European countries, 1991-2012.
Hubs to spread technology and save lives.
An economic assessment of foot and mouth disease in Japan.
Genitální bradavice a HPV vakcinace.
Cost-effective options for the prevention and management of gastrointestinal and liver disease in the Asia-Pacific region.
Cost of the Cervical Cancer Screening Program at the Mexican Social Security Institute.
Heavy Drinkers and the Potential Impact of Minimum Unit Pricing-No Single or Simple Effect?